Print

Print


Here are answers to four of Brightline's 5 excellent questions on CoQ10
from Jennifer Peters, Vitaline's Manager for Medical Communication and
Education. I have submitted the questions to a number of people, not
just Vitaline folks, and will post anything of value that I get back.

Q1.VitaLine, the company that produces and donated the COEnzyme Q wafers
used in the clinical trials.They state in their press release that only
their product has been proven safe and effective. Other brands may even
be harmful." What is the truth here? CoEQ10 must be the same protein, no
matter by what methhod or who manufactures it. Otherwise it will not be
called CoE Q10!
A1. There are two methods used to prepare CoQ10. One uses an all natural
fermentation method. The other utilizes fermentation as a starting
method, but also incorporates chemical synthesis. The two forms (natural
and synthetic) are similar, but not identical. The sythetic form
contains compounds not found in the natural form, and some medical
experts feel that this form may be less effective. However, the
synthetic form is cheaper, so some companies choose to use it. Vitaline
CoQ10 contains only the natural form of CoQ10. Also, different companies
have different manufacturing methods and standards. If the manufacturer
does not follow established GMP (good manufacturing procedures) they may
not be producing a consistent product. GMPs are not required for dietary
supplements at this time. As has been established by several independent
testing groups (such as consumerlabs.com) there is great variation among
similar products: they may not contain the amount of key ingredient
claimed, they may be contaminated with impurities during the
manufacturing process, or the key ingredient may not be correctly
identified on the label. Vitaline CoQ10 is produced in an FDA-registered
pharmaceutical manufacturing facility, affording highest quality raw
materials, lab review of raw and finished goods, as well as
manufacturing process consistency and safety.

Q2. Given that product from other manufacturers have not been tested,
does that really mean it won't be helpful or even be harmful?
A2. This is unknown. As Richard points out - if you are a person with a
serious neurodegenerative disease, why take a chance on an unproven
product simply because it is cheap? Maybe the cheap product works, maybe
it doesn't. But given the known quality issues in the dietary supplement
industry, doesn't it make sense to stick with the product that has been
proven to be safe and effective?

Q4. Vitaline CoE Q10 crosses the blood barrier successfully. Does that
mean other manufacturer's CoEQ10 would not? Or we do not know if they
do? If not, why not? Biochemically all the CoE Q10s should behave
identically. If not, what is the real active ingredient in Vitaline's
product?
A4.CoQ10 absorption is problematic. An analogy is that is it like trying
to shove an elephant through a keyhole. Manufacturers take different
approaches to ensuring absorption. One way is the use of harsh solvents
such as propylene glycol. For most people, the amount used per dose is
probably not harmful. However, people with serious neurodegenerative
diseases are taking very high doses compared to the general population,
thereby increasing their exposure to these potentially harmful
compounds.  It does not make sense to expose a vulnerable population to
these undesirable ingredients.
Vitaline's approach is different. The CoQ10 used is produced to exact
specifications, and combined with vitamin E and a proprietary delivery
system that does not use potentially harmful solvents like propylene
glycol. Research has verified that Vitaline CoQ10 increases both serum
and mitochondrial levels of CoQ10.

Q5. CoE Q10 has been tested only in the early stage patients of PD. Does
this necessarily mean it won't be effectve in late stage PDPs ,
A5. The answer is not known at this time. Research is a continuous
process. Hopefully, future studies will look at this question.


Cynthia A. Holmes, PhD
University of Arizona Department of Neurology
APDA Parkinson's Information & Referral Center
616 N. Country Club Road Suite C
Tucson, AZ 85716
Phone: (520) 326-5400
Toll-free: (800) 541-4960
FAX: (520) 326-8591
email: holmes @ u.arizona.edu

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn